Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort descending

Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs

 December 2021 Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response Statistics in Medicine

Anne A. Eaton, Emily C. Zabor

 December 2021 Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine

Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller

 January 2022 Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open

Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi

 January 2022 Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics

Fadi S.Dahdaleh, Scott K.Sherman, Hunter D.D.Witmer, Ankit Dhiman, Rahul Rajeev, Elizabeth C.Poli, Fabian M.Johnston, Kiran K.Turagaa

 January 2022 Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery

Giorgos Bakoyannis, Dipankar Bandyopadhyay

 November 2021 Nonparametric tests for multistate processes with clustered data AISM

Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger 

 February 2022 Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications

Liling Huang , Shiyu Jiang  & Yuankai Shi 

 February 2022 Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data futuremedicine

Yu, Peter MD, ET AL

 February 2022 Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times

Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov

 January 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT

Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth,  Pekka Tiikkainen, Harri Lähdesmäki

 March 2022 Learning Conditional Variational Autoencoders with Missing Covariates arXiv

T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry

 March 2022 Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel Clinical Oncology

Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai 

 March 2022 Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? Therapeutic Innovation & Regulatory Science

Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho

 April 2022 Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials Sage Journals

Pages